Nexell launches cell selection system in Europe:
This article was originally published in Clinica
Nexell Therapeutics, a subsidiary of Vimrx Pharmaceuticals has launched its second-generation Isolex 300k cell selection system in Europe. The Irvine, California-based system is the first such product with fully automated DC34+ cell selection and breast cancer cell purging capability to have received the CE mark. The new system has an improved disposable set design which is intended to improve CD34+ cell selection performance. Last month, Nexell received an approvable letter from the US FDA for the first-generation Isolex 300I system for positive selection of CD34+ cells.
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.